These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38778401)

  • 1. Mild hyperthermia enhanced synergistic uric acid degradation and multiple ROS elimination for an effective acute gout therapy.
    Zhao P; Hu HZ; Chen XT; Jiang QY; Yu XZ; Cen XL; Lin SQ; Mai SQ; Pang WL; Chen JX; Zhang Q
    J Nanobiotechnology; 2024 May; 22(1):275. PubMed ID: 38778401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Cascade Uricase/Catalase Mimics Alleviate Acute Gout.
    Lin A; Sun Z; Xu X; Zhao S; Li J; Sun H; Wang Q; Jiang Q; Wei H; Shi D
    Nano Lett; 2022 Jan; 22(1):508-516. PubMed ID: 34968071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIR triggered polydopamine coated cerium dioxide nanozyme for ameliorating acute lung injury via enhanced ROS scavenging.
    Yin M; Lei D; Liu Y; Qin T; Gao H; Lv W; Liu Q; Qin L; Jin W; Chen Y; Liang H; Wang B; Gao M; Zhang J; Lu J
    J Nanobiotechnology; 2024 Jun; 22(1):321. PubMed ID: 38849841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage.
    Chen B; Li H; Ou G; Ren L; Yang X; Zeng M
    Arthritis Res Ther; 2019 Aug; 21(1):193. PubMed ID: 31455356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape-Regulated Photothermal-Catalytic Tumor Therapy Using Polydopamine@Pt Nanozymes with the Elicitation of an Immune Response.
    Xu Z; Jiang J; Li Y; Hu T; Gu J; Zhang P; Fan L; Xi J; Han J; Guo R
    Small; 2024 May; 20(20):e2309096. PubMed ID: 38054612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection microenvironment-triggered nanoparticles eradicate MRSA by thermally amplified chemodynamic therapy and M1 macrophage.
    Hong Q; Zhang W; Liu Z; Li B; Liu X; Wang Z; Wang R; Yang J; Nie B; Yue B
    J Nanobiotechnology; 2024 Jul; 22(1):448. PubMed ID: 39080692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
    Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
    Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D Is Better: Engineering Polydopamine into Cationic Nanosheets to Enhance Anti-Inflammatory Capability.
    Liu L; Lu C; Tao Z; Zha Z; Wang H; Miao Z
    Adv Healthc Mater; 2024 Jul; 13(18):e2400048. PubMed ID: 38466315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS.
    Ma Z; Tian X; Yu S; Shu W; Zhang C; Zhang L; Wang F
    Mol Pharm; 2024 Jun; 21(6):3040-3052. PubMed ID: 38767388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Based on polydopamine-coated metal organic framework multifunctional nanoplatform for enhanced photothermal/sonodynamicand treatment combined with checkpoint blockade therapy.
    Bai Z; Huang J; Lu H; Wang N; Li H; Zhu Y
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132207. PubMed ID: 38723823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Synthesis of New PEGylated Polydopamine-Based Nanoconstructs Bearing ROS-Responsive Linkers and a Photosensitizer for Bimodal Photothermal and Photodynamic Therapies against Cancer.
    Zmerli I; Ibrahim N; Cressey P; Denis S; Makky A
    Mol Pharm; 2021 Sep; 18(9):3623-3637. PubMed ID: 34431682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-synergistic effect of Prussian blue nanoparticles for cancer therapy: driving photothermal therapy and reducing hyperthermia-induced side effects.
    Xie X; Gao W; Hao J; Wu J; Cai X; Zheng Y
    J Nanobiotechnology; 2021 May; 19(1):126. PubMed ID: 33947395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidity-Responsive Fe-PDA@CaCO
    Zhao F; Wang C; Wang H; Ying Y; Li W; Li J; Zheng J; Qiao L; Che S; Yu J
    ACS Appl Mater Interfaces; 2024 Aug; 16(33):43364-43373. PubMed ID: 39105706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIR-PTT/ROS-Scavenging/Oxygen-Enriched Synergetic Therapy for Rheumatoid Arthritis by a pH-Responsive Hybrid CeO
    Chen MW; Lu QJ; Chen YJ; Hou YK; Zou YM; Zhou Q; Zhang WH; Yuan LX; Chen JX
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3361-3376. PubMed ID: 35819069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Stimuli-Responsive Multifunctional Gd
    Kuang Y; Zhang Y; Zhao Y; Cao Y; Zhang Y; Chong Y; Pei R
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):35928-35939. PubMed ID: 32686939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hollow Cavity CaO
    Wang Y; Wang S; Li S; Zhen W; Jia X; Jiang X
    Adv Healthc Mater; 2024 Feb; 13(5):e2302634. PubMed ID: 37992213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shuttle-Shape Carrier-Free Platinum-Coordinated Nanoreactors with O
    Fu X; Yin W; Shi D; Yang Y; He S; Hai J; Hou Z; Fan Z; Zhang D
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32690-32702. PubMed ID: 34229434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Human Proteoglycan 4 Regulates Phagocytic Activation of Monocytes and Reduces IL-1β Secretion by Urate Crystal Stimulated Gout PBMCs.
    ElSayed S; Jay GD; Cabezas R; Qadri M; Schmidt TA; Elsaid KA
    Front Immunol; 2021; 12():771677. PubMed ID: 34992596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intelligent Hollow Pt-CuS Janus Architecture for Synergistic Catalysis-Enhanced Sonodynamic and Photothermal Cancer Therapy.
    Liang S; Deng X; Chang Y; Sun C; Shao S; Xie Z; Xiao X; Ma P; Zhang H; Cheng Z; Lin J
    Nano Lett; 2019 Jun; 19(6):4134-4145. PubMed ID: 31084016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB Activation.
    Dhanasekar C; Kalaiselvan S; Rasool M
    PLoS One; 2015; 10(12):e0145093. PubMed ID: 26709520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.